BIOMAT Database Logo BIOMAT Database Logo

FoxP3+ regulatory T cells suppress effector T-cell function at pathologic site in miliary tuberculosis. 2009

Prabhat K Sharma, and Pradip K Saha, and Amar Singh, and Surendra K Sharma, and Balaram Ghosh, and Dipendra K Mitra
Department of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India.

BACKGROUND The inadequacy of effector T-cell response in containment of tubercle bacilli is believed to result in the development of disseminated forms of tuberculosis (TB), such as miliary tuberculosis (MTB). Regulatory T cells (Treg) plausibly play a critical role in the immunopathogenesis of disseminated TB by suppression of effector immune response against Mycobacterium tuberculosis at the pathologic site(s). To understand the role of Treg cells in disseminated tuberculosis, we studied the frequency and function of Treg cells derived from the local disease site specimens (LDSS) of patients with TB pleural effusion and MTB as clinical models of contained and disseminated forms of disease, respectively. OBJECTIVE To (1) enumerate the frequency of Treg cells in bronchoalveolar lavage (BAL) fluid of patients with MTB and compare with that of peripheral blood, (2) study the role of Treg cells in suppression of local T-cell response, and (3) study the selective recruitment of Treg cells at the local disease site(s). METHODS Flow cytometry, reverse transcriptase polymerase chain reaction, and 3-(4,5-dimethylthythiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT)-based cell proliferation assay. RESULTS Frequency of Treg cells (CD4(+)CD25(+)FoxP3(+)) was significantly higher in LDSS in MTB along with higher levels of FoxP3 mRNA. Importantly, FoxP3(+) Treg cells obtained from the BAL of patients with MTB predominantly produced IL-10 and could suppress the autologous T-cell proliferation in response to M. tuberculosis antigen. CONCLUSIONS Our results highlight the importance of Treg cells in suppression of effector immune response and their influence on bacillary dissemination, disease manifestation, and severity.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010996 Pleural Effusion Presence of fluid in the pleural cavity resulting from excessive transudation or exudation from the pleural surfaces. It is a sign of disease and not a diagnosis in itself. Effusion, Pleural,Effusions, Pleural,Pleural Effusions
D001992 Bronchoalveolar Lavage Fluid Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung. Alveolar Lavage Fluid,Bronchial Lavage Fluid,Lung Lavage Fluid,Bronchial Alveolar Lavage Fluid,Lavage Fluid, Bronchial,Lavage Fluid, Lung,Pulmonary Lavage Fluid,Alveolar Lavage Fluids,Bronchial Lavage Fluids,Bronchoalveolar Lavage Fluids,Lavage Fluid, Alveolar,Lavage Fluid, Bronchoalveolar,Lavage Fluid, Pulmonary,Lavage Fluids, Alveolar,Lavage Fluids, Bronchial,Lavage Fluids, Bronchoalveolar,Lavage Fluids, Lung,Lavage Fluids, Pulmonary,Lung Lavage Fluids,Pulmonary Lavage Fluids
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014391 Tuberculosis, Miliary An acute form of TUBERCULOSIS in which minute tubercles are formed in a number of organs of the body due to dissemination of the bacilli through the blood stream. Miliary Tuberculoses,Miliary Tuberculosis,Tuberculoses, Miliary
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control

Related Publications

Prabhat K Sharma, and Pradip K Saha, and Amar Singh, and Surendra K Sharma, and Balaram Ghosh, and Dipendra K Mitra
Regulatory T cells suppress T cell activation at the pathologic site of human visceral leishmaniasis.
January 2012, PloS one,
Prabhat K Sharma, and Pradip K Saha, and Amar Singh, and Surendra K Sharma, and Balaram Ghosh, and Dipendra K Mitra
Differentiation and function of Foxp3(+) effector regulatory T cells.
February 2013, Trends in immunology,
Prabhat K Sharma, and Pradip K Saha, and Amar Singh, and Surendra K Sharma, and Balaram Ghosh, and Dipendra K Mitra
Programmed death-1+ T cells inhibit effector T cells at the pathological site of miliary tuberculosis.
February 2017, Clinical and experimental immunology,
Prabhat K Sharma, and Pradip K Saha, and Amar Singh, and Surendra K Sharma, and Balaram Ghosh, and Dipendra K Mitra
Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation.
July 2006, Immunity,
Prabhat K Sharma, and Pradip K Saha, and Amar Singh, and Surendra K Sharma, and Balaram Ghosh, and Dipendra K Mitra
CD4+ Foxp3+ regulatory T cells suppress γδ T-cell effector functions in a model of T-cell-induced mucosal inflammation.
December 2011, European journal of immunology,
Prabhat K Sharma, and Pradip K Saha, and Amar Singh, and Surendra K Sharma, and Balaram Ghosh, and Dipendra K Mitra
CD4+ FOXP3+ Regulatory T Cells Exhibit Impaired Ability to Suppress Effector T Cell Proliferation in Patients with Turner Syndrome.
January 2015, PloS one,
Prabhat K Sharma, and Pradip K Saha, and Amar Singh, and Surendra K Sharma, and Balaram Ghosh, and Dipendra K Mitra
Increased CD4+Foxp3+ T cells in BAFF-transgenic mice suppress T cell effector responses.
January 2009, Journal of immunology (Baltimore, Md. : 1950),
Prabhat K Sharma, and Pradip K Saha, and Amar Singh, and Surendra K Sharma, and Balaram Ghosh, and Dipendra K Mitra
Foxp3(+) regulatory T cells in tuberculosis.
January 2013, Advances in experimental medicine and biology,
Prabhat K Sharma, and Pradip K Saha, and Amar Singh, and Surendra K Sharma, and Balaram Ghosh, and Dipendra K Mitra
Regulatory T Cells Suppress Effector T Cell Proliferation by Limiting Division Destiny.
January 2018, Frontiers in immunology,
Prabhat K Sharma, and Pradip K Saha, and Amar Singh, and Surendra K Sharma, and Balaram Ghosh, and Dipendra K Mitra
CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
April 2009, Clinical immunology (Orlando, Fla.),
Copied contents to your clipboard!